| | |
| Clinical data | |
|---|---|
| Other names | Glu-Asp-Arg |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| Chemical and physical data | |
| Formula | C15H26N6O8 |
| Molar mass | 418.407 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pinealon, also known as EDR peptide, is a synthetic tripeptide of sequence (Glu-Asp-Arg) and purported geroprotector documented in the Russian scientific literature. [1] [2] [3] [4] [5] [6] Pinealon is one of several tripeptide "bioregulators" developed in Russia. [7] [8] [9]
Pinealon has been shown to protect rat offspring from prenatal hyperhomocysteinemia and correspondingly improve post natal cognitive function. [10]
Pinealon likewise maintains learning retention rats with experimentally-induced diabetes. [11]
Pinealon is a tripeptide composed of L-glutamic acid, L-aspartic acid, and L-arginine and is notated as Glu-Asp-Arg or EDR. [12]